Lumentum Holdings Inc. (LITE)
Quantitative Summary
DeterministicLITE trades at 151.6x earnings — a 133% premium to its sector average of 65.0x — without a dominant ROIC-WACC spread. Financial health metrics are strong: Piotroski 7/9, Altman Z 12.8 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics reveal a stark divergence between high-growth momentum and deteriorating capital efficiency. While the company demonstrates robust top-line expansion with 21% year-over-year revenue growth, supported by strong governance signals such as an Altman Z-Score of 10.4 and a Beneish M-Score of -2.49 suggesting low earnings manipulation risk, its core profitability metrics are under severe strain. The DuPont decomposition highlights that the modest 2.3% ROE is driven almost entirely by financial leverage (Equity Multiplier of 3.72x) rather than operational excellence, as evidenced by a negligible net margin of 1.6% and low asset turnover of 0.39x. This structural weakness is compounded by a deeply negative ROIC-WACC spread of -16.1%, indicating that the firm's investments are currently destroying value relative to its cost of capital, despite maintaining a respectable Piotroski F-Score of 7/9.
Valuation metrics reflect extreme market optimism regarding future growth potential rather than current earnings power. Trading at a P/E ratio of 238.3x, which is significantly elevated against historical norms and likely the sector average given the unknown classification, the stock price implies an aggressive reinvestment thesis necessary to sustain its trajectory. A Discounted Cash Flow analysis would struggle to justify this multiple unless investors assume perpetual acceleration in net margins or a substantial reduction in the cost of capital; currently, the market appears pricing in a transformation from a low-margin operator into a high-return compounder. The Fama-French alpha of 72.17% suggests significant outperformance relative to traditional factor models, yet this is counterbalanced by negative exposures to the Value (HML: -0.615) and Profitability (RMW: -0.112) factors, indicating that standard value investing frameworks view the security as overvalued based on current fundamentals.
Risk assessment presents a complex picture of high factor risk amid mixed insider sentiment. The pronounced growth tilt in the HML score and weak profitability signal in RMW expose the stock to heightened vulnerability if margin expansion fails to materialize or if macroeconomic headwinds compress asset turnover. Furthermore, while quantitative models show strong alpha generation, recent insider activity over the last 90 days indicates a net outflow of $37.15 million, suggesting that management may be less confident in near-term prospects than external algorithms imply. Investors must weigh whether the historical factor performance can persist despite these deteriorating operational spreads and significant capital distribution by insiders.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Valuation Context
Currently trading 87% above its 5-year average P/E of 141.0x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedLumentum Holdings Inc. is currently trading at $976.18, a price point that requires contextualization against its moving average envelope to assess relative value and potential mean-reversion dynamics. Without specific data regarding the upper or lower bounds of this technical channel, the immediate implication remains ambiguous; however, if the current valuation sits significantly distant from these statistical averages, it suggests an extended deviation that historically often precedes a corrective swing toward equilibrium. Conversely, if the price resides near the centerline or within the normal confines of the envelope, the asset may be exhibiting stable consolidation rather than signaling an imminent reversal. The position relative to these moving averages serves as a critical gauge for identifying whether the stock is overextended in either direction or maintaining a balanced state consistent with its recent trading range. In the absence of defined channel boundaries, determining the precise probability of a mean-reversion event relies on comparing the $976.18 level against historical volatility metrics encapsulated by the SMA bands. A price far removed from these lines typically indicates heightened momentum that may eventually exhaust itself, whereas proximity to the envelope suggests the market is already pricing in recent trends with less room for sharp corrections based solely on mean-reversion logic. Traders observing this setup must weigh whether the current distance from the average represents a temporary anomaly or a structural shift, noting that extreme deviations often invite counter-trend pressure while neutral positions may sustain their trajectory longer. Ultimately, the technical narrative hinges entirely on where $97
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like IYZ or XTL, the fund manager is mechanically forced to buy or sell LITE shares regardless of Lumentum Holdings Inc.'s individual fundamentals. We estimate $7.5B of passive capital is structurally linked to LITE through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Lumentum Holdings Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Lumentum Holdings Inc. (LITE) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Cisco Systems Inc (CSCO) as the most exposed collateral stock, sharing 1 ETFs with LITE. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 23 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
LITE Ownership Dynamics
Passive funds hold 1 in every 8 LITE shares, reducing daily market volatility.
Lumentum Holdings Inc. (LITE) exerts measurable gravity on the passive index market, currently representing 4.7% of the IYZ (IYZ) and 4.0% of the XTL (XTL). Across 22 tracked ETFs, approximately 10M shares (12.8% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest LITE Exposure
Float lock-up computed from 22 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
LITE Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Lumentum Holdings Inc. over the past year sits near $148.29 (13% of 252-day volume). The current price of $1029.15 trades 594.0% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (13% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
LITE Capital Efficiency
How efficiently does Lumentum Holdings Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Lumentum Holdings Inc. converts -98% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 198% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-16.1%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 158 | $1030.37 | $162,798.46 |
| 2026-05-13 | 1,166 | $992.37 | $1.2M |
| 2026-05-11 | 854 | $903.80 | $771,845.2 |
| 2026-05-07 | 362 | $944.28 | $341,829.36 |
| 2026-05-06 | 1,724 | $994.56 | $1.7M |
| 2026-05-05 | 1,720 | $976.18 | $1.7M |
| 2026-05-01 | 2,147 | $902.32 | $1.9M |
| 2026-04-30 | 4 | $858.32 | $3,433.28 |
| 2026-04-27 | 9,182 | $881.64 | $8.1M |
| 2026-04-23 | 1 | $873.60 | $873.6 |
| 2026-04-22 | 766 | $836.92 | $641,080.72 |
| 2026-04-21 | 298 | $895.11 | $266,742.78 |
| 2026-04-20 | 6,853 | $894.07 | $6.1M |
| 2026-04-16 | 72 | $824.01 | $59,328.72 |
| 2026-04-15 | 487 | $852.79 | $415,308.73 |
| 2026-04-14 | 563 | $871.18 | $490,474.34 |
| 2026-04-10 | 98 | $894.13 | $87,624.74 |
| 2026-04-06 | 10,316 | $826.88 | $8.5M |
| 2026-04-02 | 43 | $764.65 | $32,879.95 |
| 2026-03-27 | 10,656 | $688.80 | $7.3M |
| 2026-03-25 | 3,277 | $801.99 | $2.6M |
| 2026-03-24 | 1,800 | $728.95 | $1.3M |
| 2026-03-23 | 49,530 | $706.35 | $35.0M |
| 2026-03-20 | 342 | $772.13 | $264,068.46 |
| 2026-03-19 | 495 | $700.81 | $346,900.95 |
| 2026-03-16 | 144 | $622.50 | $89,640 |
| 2026-03-13 | 11 | $616.09 | $6,776.99 |
| 2026-03-10 | 76,899 | $640.69 | $49.3M |
| 2026-03-09 | 180,130 | $558.44 | $100.6M |
| 2026-03-04 | 9,163 | $694.43 | $6.4M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| COHR | 0.713 | 0.745 | High co-movement |
| CIEN | 0.656 | 0.709 | Moderate |
| FN | 0.642 | 0.666 | Moderate |
| GLW | 0.617 | 0.648 | Moderate |
| LRCX | 0.543 | 0.557 | Moderate |
| VRT | 0.535 | 0.534 | Moderate |
| SNDK | 0.535 | 0.547 | Moderate |
| AAOI | 0.525 | 0.527 | Moderate |
| MU | 0.523 | 0.513 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare LITE to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.